1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
You may not appreciate it. You may not have even noticed it. But small-cap stocks have led the way since the market came out of the subprime slump in 2009.
That lead has widened considerably...
While everyone piles into the same ol' blue chips, get yield at a relative value via these lesser-known names
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the...
More Investing News »